The next level of TMS Therapy

sync2brain

Transcranial Magnetic Stimulation is increasingly establishing itself as a new treatment method for strokes, depression and other diseases.

And we make it even better …

Learn More

See our new image video!

Join Us!

Do you want to join a purpose driven company and community and become part of our team?

This is your chance: We are looking for a Quality and Regulatory Affairs Manager (w, m, d)!

purpose – yes.
responsibility – yes.
self-efficacy – yes.
room to grow – yes.
flexibility – oh yes.

Let’s talk!

Why we exist

Our mission is to develop new personalized brain-stimulation therapies for patients suffering from neuropsychiatric disease such as stroke or depression.



Impact on Neuroscience

We enable studying the transient large-scale dynamics of the human brain with easy-to-program real-time signal processing technology that reads a stream of EEG data and triggers stimulation during pre-defined oscillatory brain-states.

P

Impact on Medicine

We believe that this technology will unlock the therapeutic potential of non-invasive brain stimulation.



Impact on Healthcare System

TMS, especially personalized TMS therapy, can improve or replace other therapy forms for common diseases, often at a fraction of their costs.

Next-Generation TMS

sync2brain technology is enabling a wide range of basic science, clinical research, and technology partnership.

Clinical Studies

Research Labs

Patients

Grants in EUR

About US

sync2brain was founded out of a technology transfer research project at the University of Tübingen with support by a grant from the German ministry of economic affairs in the EXIST Transfer of Research program, with support from the European Social Fund.

Meet our Team, …

Dr. Ramona Samba

CEO

LinkedIn

Dr. Brigitte Zrenner

Clinical Studies & Co-Founder

Dr. Christoph Zrenner

CTO & Co-Founder

Niko Mangold

Head of Quality Assurance and Regulatory Affairs

LinkedIn

Dr. Gabor Kozak

Technical Development and Senior Scientist

LinkedIn

Umair Hassan

Technical Development and Senior Scientist

LinkedIn

Henrike Stutzki

Head of Clinical Affairs

LinkedIn

You?

Message us on LinkedIn!

If you want to be part of our innovative team and want to improve the world of neurostimulation, message us on LinkedIn for an unsolicited application. We look forward to meeting you!

LinkedIn

TMS in Stroke
Neurorehabilitation

TMS therapy is offered at the TMS clinic at the University Neurology Hospital of Tübingen, including clinical trials with sync2brain technology. Please see www.tms-nach-schlaganfall.de for details and to schedule an appointment for an evaluation. An application to the insurance company for reimbursement of the therapy cost is recommended.

Coverage in Media

03.05.2020

The PRODUCT

We are currently preparing the CE certification of the bossdevice MEDICAL as a medical device. Once certified, it may be used with compatible EEG amplifiers and compatible TMS stimulators for closed loop TMS experiments and therapy. Stay connected for updates!